FDA authorizes first prescription antibody test to collect blood sample at home
The Food and Drug Administration today authorized for emergency use the first prescription antibody test that allows individuals to collect a finger-stick dried blood sample at home for analysis at a Symbiotica laboratory when a health care provider deems it appropriate.
The COVID-19 Self-Collected Antibody Test System can help identify individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.
Related News Articles
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention…
Headline
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…
Headline
The Centers for Medicare & Medicaid Services Oct. 22 released final guidance detailing reporting requirements for the hospital respiratory data condition…
Headline
The Food and Drug Administration Aug. 22 granted emergency use authorization for two new combined COVID-19 and influenza tests. The Nano-Check Influenza-COVID-…
Headline
The Centers for Disease Control and Prevention's COVID-19 data tracker shows an 18.1% test positivity rate for the week ending Aug. 10, the highest it has been…
Headline
The Centers for Disease Control and Prevention Aug. 13 issued an advisory alerting of an uptick of cases of parvovirus B19 across the U.S. Parvovirus B19 is a…